Combined 99mTc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules: reply to comments by Riazi et al.

[1]  Sarah J. Johnson,et al.  Guidelines for the management of thyroid cancer , 2014, Clinical endocrinology.

[2]  I. Nabipour,et al.  Comments on Wale et al. : Combined 99mTc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  K. Miles,et al.  Combined 99mTc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  F. Mottaghy,et al.  Cost-effectiveness of 99mTc-MIBI in the evaluation of thyroid nodules for malignancy: a new lease of life for an old radiopharmaceutical? , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  A. Lowe,et al.  Fine-Needle Aspiration May Miss a Third of All Malignancy in Palpable Thyroid Nodules: A Comprehensive Literature Review , 2007, Annals of surgery.

[6]  L. M..  A a , 2004 .

[7]  E. Hovorková,et al.  Sensitivity and specificity of the fine needle aspiration biopsy of the thyroid: clinical point of view , 1999, Clinical endocrinology.

[8]  A. Pontecorvi,et al.  Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. , 1998, Thyroid : official journal of the American Thyroid Association.